FLT3 and acute myeloid leukemia: In NPM1/FLT3 co-mutated AML, concurrent menin and FLT3 inhibition dismantles cooperative HOX-dependent fitness while suppressing mitogenic drive, offering a chemo-sparing strategy (Carter et al., 2023).